WFL 0.00% 0.3¢ wellfully limited

3 products - over 800K products delivered P&G says numbers will...

  1. 5,224 Posts.
    lightbulb Created with Sketch. 2
    3 products - over 800K products delivered
    P&G says numbers will keep going up
    first wand phasing out, new development to replace original wand
    Wave 2 will continue into 2018
    Magnemask wave 3 - largest volume and fastest growing - 2018 and America
    Wave 4 soon
    2nd technology licence agreement before the AGM hopefully?

    Bodyguard - successful trial - pre-production devices ready for distribution to major international companies
    Commercialisation target 2018
    Surface hygience - two major multinationals interested. Data shows 500% improvement surface penetration?

    Bloody call keeps breaking up - I am missing half if it

    Summary
    Corporate - new chairman recruitment will under way
    Patents increasing in number and costs
    Decreasing overall expenditure however

    Answers to Questions
    Corporate Partners other than P&G? Keen to diversify, likely in hair care, but more likely to be Bodyguard - partners are in US, UK, Japan, Europe. 2 want to use their own chemistry. Bodyguard is complex. Surface hygience plus other activity with other companies

    Pfizer - couldn't really talk about it.

    Curtin trial - results early next year

    Commercialisation of surface hygience? - moving through validation, hopefully 2018 with atleast one partner
    Oral healthcare? - stop start progress, GSK results were highly successful, but P&G has picked up the opportuniuty through oral B line, Design on first product very well received
    Shaving? - disappointed by market dynamics - unstable

    P&G recouping R&D costs prior to royalties - no R&D deducted, royalty 2-3% is clean
    Cash flow positive? - close to cash flow positive next 2 quarters, will not raise capital, hoping for sustained increase
    Earnings expectations per quarters? - just at the start of the rollout, hard to forecast right now because of P&G because it is early. Good info from P&G last week but waiting for validation before notifying market

    Commercialisation micro needles? - not and the moment, no interest, will evolve into something else maybe

    Dr Borman article? 3-5% royalty is possible but made it clear that 2-3% is what they are getting.

    Accelerators? Met with one in Singapore aligned with P&G - related to other skin care products, another in the US interested in Bodyguard

    Coty? Testing of protoypes? Products when? Coty acquired brands from P&G which changed its business. Met recently with Coty and working towards getting a deal. Meeting again next week. 2nd technology can apply to Coty.

    Tube cap will find partner

    Wave 4 will be launched in 1st half of 2018 - copackaged like the other products. Will be standalone but a fully integrated (bundled?) product will be released.

    2nd Technology - licence very close, launch plan must be provided within 18 months and licence fees within 30 months. 1000 person consumer trial in 2018 which will define how they introduce products

    Share performance plan - no directors will be involved

    Told by P&G that product timeline is out to 2021 and 2nd tech revenue later next year according to P&G

    Very positive about the future

    Overall OBJ is on the first step upwards. Took many years to incorporate the physics of OBJ tech into products. Over 850K world first products shipped/built. More recent launches have gone extremely well - far better than expected.

    Look forward to years of developing 2nd Tech with various partners

    OBJ the foremost supplier of product innovation

    The business will grow in leaps and bounds.

    Will do conference calls more often
 
watchlist Created with Sketch. Add WFL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.